Pulmonx entered the week with an updated price target that still signals meaningful upside, even as analysts modestly tweak their assumptions around risk and growth. With fair value steady at $5.75 ...
Ralliant's estimated fair value is US$49.37 based on 2 Stage Free Cash Flow to Equity. Ralliant's US$51.65 share price indicates it is trading at similar levels as i ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback